- Home
- TCRX vs JEQ Comparison
TCRX vs JEQ Comparison
Compare TCRX & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- JEQ
- Stock Information
- Founded
- TCRX 2018
- JEQ 1990
- Country
- TCRX United States
- JEQ United States
- Employees
- TCRX N/A
- JEQ N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- JEQ Air Freight/Delivery Services
- Sector
- TCRX Health Care
- JEQ Consumer Discretionary
- Exchange
- TCRX Nasdaq
- JEQ Nasdaq
- Market Cap
- TCRX 90.5M
- JEQ 88.1M
- IPO Year
- TCRX 2021
- JEQ N/A
- Fundamental
- Price
- TCRX $1.45
- JEQ $7.17
- Analyst Decision
- TCRX Strong Buy
- JEQ
- Analyst Count
- TCRX 6
- JEQ 0
- Target Price
- TCRX $9.50
- JEQ N/A
- AVG Volume (30 Days)
- TCRX 774.8K
- JEQ 32.0K
- Earning Date
- TCRX 05-06-2025
- JEQ 01-01-0001
- Dividend Yield
- TCRX N/A
- JEQ 7.05%
- EPS Growth
- TCRX N/A
- JEQ N/A
- EPS
- TCRX N/A
- JEQ N/A
- Revenue
- TCRX $4,421,000.00
- JEQ N/A
- Revenue This Year
- TCRX $68.86
- JEQ N/A
- Revenue Next Year
- TCRX $14.01
- JEQ N/A
- P/E Ratio
- TCRX N/A
- JEQ N/A
- Revenue Growth
- TCRX N/A
- JEQ N/A
- 52 Week Low
- TCRX $1.02
- JEQ $4.99
- 52 Week High
- TCRX $9.29
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- TCRX 49.42
- JEQ 66.89
- Support Level
- TCRX $1.33
- JEQ $6.94
- Resistance Level
- TCRX $1.49
- JEQ $7.21
- Average True Range (ATR)
- TCRX 0.11
- JEQ 0.07
- MACD
- TCRX 0.02
- JEQ -0.00
- Stochastic Oscillator
- TCRX 69.12
- JEQ 87.88
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.